Multi-Faceted Intervention to Limit Over-Prescription of Proton Pump Inhibitors: A Quasi Experimental Study
DOI:
https://doi.org/10.51253/pafmj.v76i3.12068Keywords:
Inappropriate Prescription, Multifaceted Intervention, Prescriptions, Proton Pump InhibitorsAbstract
Objective: To assess knowledge and attitude regarding over-prescription of PPI, and to utilize multi-faceted educational interventions to reduce inappropriate and unwanted usage of PPIs.
Study Design: Quasi-experimental study.
Place and Duration of Study: Pak Emirates Military Hospital, and Combined Military Hospital Rawalpindi, Pakistan from Aug 2022 to Jan 2024.
Methodology: A total of 807 doctors were included in the study, 395 doctors as Group-A and 412 doctors were taken as Group-B. Group-A doctors were given questionnaires at start and end of intervention at PEMH, and doctors of Group-B were given questionnaires in CMH post-experimentally, as no educational intervention was done on them. Multifaceted intervention was used to find out the primary and secondary outcomes.
Results: Mean age of Group-A was 32.3±3.6 years, and Group-B was 30.2±2.5 years. Knowledge of the study groups was almost the same before intervention. Prescribing knowledge of PPI in Group-A (n=395) improved before and after educational intervention. Most common question which showed drastic change before and after intervention was “Duration of PPI prophylaxis is until no high-risk factors, or able to tolerate enteral feeding?” Before intervention 329(83.3%) vs after intervention 42 (10.6), with a p-value <0.001.
Conclusion: Prescribing knowledge of proton pump inhibitors (PPI) in study participants improved before and after educational intervention.
Downloads
References
1. Shanika LG, Reynolds A, Pattison S, Braund R. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol 2023; 79(9): 1159-1172.
https://doi.org/10.1007/s00228-023-03534-z
2. Mishuk AU, Chen L, Gaillard P, Westrick S, Hansen RA, Qian J. National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017. J Am Pharm Assoc 2021; 61(1): 87-94.
https://doi.org/10.1016/j.japh.2020.09.015
3. Samar R, Ali SA, Samar V, Mushtaq MZ, Humayun A. Inappropriate use of proton pump inhibitor for stress ulcer prophylaxis in a tertiary care hospital in Karachi, Pakistan. Pak J Pharm Sci 2021; 34(6): 2253-2255.
https://doi.org/10.36721/PJPS.0000.00.0.REG.000-000.1
4. Butt AK, Hashemy I. Risk factors and prescription patterns of gastroesophageal reflux disease: HEAL study in Pakistan. J Pak Med Assoc 2014; 64(7): 751-757.
5. Voukelatou P, Vrettos I, Emmanouilidou G, Dodos K, Skotsimara G, Kontogeorgou D. Predictors of inappropriate proton pump inhibitors use in elderly patients. Curr Gerontol Geriatr Res 2019; 2019(1): 7591045.
https://doi.org/10.1155/2019/7591045
6. Lanas A. We are using too many PPIs, and we need to stop: a European perspective. Am J Gastroenterol 2016; 111(8): 1085-1086. https://doi.org/10.1038/ajg.2016.166
7. MacRae C, Mercer S, Guthrie B. Potentially inappropriate primary care prescribing in people with chronic kidney disease: a cross-sectional analysis of a large population cohort. Br J Gen Pract 2021; 71(708): e483-490.
https://doi.org/10.3399/BJGP.2020.0871
8. Li G, Andrews HF, Chihuri S, Lang BH, Leu CS, Merle DP, et al. Prevalence of potentially inappropriate medication use in older drivers. BMC Geriatr 2019; 19: 1-8.
https://doi.org/10.1186/s12877-019-1287-8
9. Alshamsi F, Belley-Cote E, Cook D, Almenawer SA, Alqahtani Z, Perri D, et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 2016; 20: 1-2. https://doi.org/10.1186/s13054-016-1305-6
10. Clarke K, Adler N, Agrawal D, Bhakta D, Sata SS, Singh S, et al. Reducing overuse of proton pump inhibitors for stress ulcer prophylaxis and nonvariceal gastrointestinal bleeding in the hospital: a narrative review and implementation guide. J Hosp Med 2021; 16(7): 417-423.
https://doi.org/10.12788/jhm.3637
11. Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 2016; 73(4): 410-416.
https://doi.org/10.1001/jamaneurol.2015.4791
12. Chan JL, El-Serag HB. Is proton pump inhibitor use associated with risk of myocardial infarction? Gastroenterology 2016; 150(2): 526-527.
https://doi.org/10.1053/j.gastro.2015.12.016
13. Luo H, Fan Q, Bian T, Li X, Chen K, Zhang Q, et al. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China. BMC Health Serv Res 2019; 19: 1-9.
https://doi.org/10.1186/s12913-019-4725-6
14. Eken E, Estores DS, Cicali EJ, Wiisanen KK, Johnson JA. A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps. Pharmacogenomics Pers Med 2023; 2023: 645-664.
https://doi.org/10.2147/PGPM.S371994
15. Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016; 176(2): 238-246.
https://doi.org/10.1001/jamainternmed.2015.7193
16. Hakami OA, Alsubaie RA, Albaqami BA, Almutlaq HM, Alqahtani NM, Alkhonezan M, et al. Knowledge and Perception of Physicians of Different Specialties in Saudi Arabia Toward Helicobacter pylori. J Multidiscip Healthc 2023; 2023(1): 763-771.
https://doi.org/10.2147/JMDH.S403999
17. Ierardi E, Losurdo G, LaFortezza RF, Principi M, Barone M, DiLeo A. Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness. World J Gastroenterol 2019; 25(34): 5097.
https://doi.org/10.3748/wjg.v25.i34.5097
18. Mustafa AG, Aslam A, Aamir M, Jamshed S, Akhtar SS. Evaluating Lifestyle and Educational Factors Influencing Public Knowledge, Attitudes, and Practices Toward Helicobacter pylori‐Induced Gastric Ulcer: A Cross‐Sectional Study. Health Sci Rep 2026; 9(4): e72286.
https://doi.org/10.1002/hsr2.72286
19. Hussain S, Stefan M, Visintainer P. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients. South Med J 2010; 103(11): 1103–1110.
https://doi.org/10.1097/SMJ.0b013e3181f6539d
20. Koczka CP, Geraldino-Pardilla LB, Goodman AJ. Physicians' opinions of stress ulcer prophylaxis: survey results from a large urban medical center. Dig Dis Sci 2013; 58(3): 777–781.
https://doi.org/10.1007/s10620-012-2423-x
21. Mustafa ZU, Haroon S, Aslam N, Saeed A, Salman M, Hayat K, et al. Exploring Pakistani Physicians' Knowledge and Practices Regarding High Alert Medications: Findings and Implications. Front Pharmacol 2022; 13: 744038.
https://doi.org/10.3389/fphar.2022.744038
22. Xing X, Bai X, Chu Y, Hou K, Yan S. Retrospective analysis of the effect of acid suppressant on the prevention of stress ulcer in perioperative inpatients. J Clin Therap 2018; 16(01): 55–60.
https://doi.org/10.1186/s12876-021-01979-z
23. Xing XX, Zhu C, Chu YQ, Bai XR, Wang K, Zhang ST. Physicians’ knowledge, attitude, and prescribing behavior regarding stress ulcer prophylaxis in China: a multi-center study. BMC Gastroenterol 2021; 21(1): 1-8.
https://doi.org/10.1186/s12876-021-01979-z
24. Al-Dosari BS, Binafeef BM, Alsolami SA. Prescribing pattern of proton pump inhibitors among patients admitted to medical ward at King Abdulaziz University Hospital, Jeddah, Saudi Arabia: A retrospective study. Saudi Med J 2021; 42(12): 1313.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Rabia Afroz, Shazia Nisar, Maryam Khan, Tehreem Khan, Sobia Latif, Fatima Farooq
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
